-
International Journal of Chronic Obstructive Pulmonary Disease
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Use of azithromycin in the treatment of acute exacerbations of COPD
Review
(3262) Views (935) Full article downloads
Authors: Aaron P Milstone
Published Date August 2008
Volume 2008:3(4) Pages 515 - 520
DOI: http://dx.doi.org/10.2147/COPD.S1189
Aaron P Milstone
Division of Allergy, Pulmonary and Critical Care, Vanderbilt University Medical Center, Nashville, TN, USA
Abstract: Chronic bronchitis is a relatively common entity among patients with underlying chronic obstructive lung disease. Typical treatment includes pulmonary hygiene, bronchodilators, and antimicrobial therapy. In recent years, the duration of antimicrobial therapy in acute exacerbations of COPD has become shorter and shorter. This review summarizes the data on the use of the drug azithromycin for this particular patient population with a focus on 3-day and single-day therapy.
Keywords: COPD acute exacerbation, macrolide, azithromycin
Readers of this article also read:
Noninvasive ventilation in patients with chronic obstructive airway disease
Mechanisms of improvement of respiratory failure in patients with COPD treated with NIV
Preferential recruitment of neutrophils by endothelin-1 in acute lung inflammation induced by lipopolysaccharide or cigarette smoke
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
The pathophysiology of bronchiectasis
Antibiotic treatment of exacerbations of COPD in general practice: long-term impact on healthrelated quality of life
Development and implementation of treadmill exercise testing protocols in COPD
Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations
Neuropathic diabetic foot ulcers – evidence-to-practice
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
- The pathophysiology of bronchiectasis
- Exacerbation rate, health status and mortality in COPD – a review of potential interventions
